TCS7010
TCS7010 is a potent and highly selective Aurora A inhibitor with with an IC50 of 3.4 nM.
Product Specifications
CAS Number
1158838-45-9
UNSPSC
12352005
Hazard Statement
H302
Target
Apoptosis; Aurora Kinase
Type
Reference compound
Related Pathways
Apoptosis; Cell Cycle/DNA Damage; Epigenetics
Applications
Cancer-Kinase/protease
Field of Research
Cancer
Assay Protocol
https://www.medchemexpress.com/aurora-a-inhibitor-i.html
Purity
99.82
Solubility
DMSO : 50 mg/mL (ultrasonic)
Smiles
O=C(C1=CC=C(C=C1)NC2=C(F)C=NC(NC3=CC=C(C=C3)CC(N4CCN(CC4)CC)=O)=N2)NC5=CC=CC=C5Cl
Molecular Formula
C31H31ClFN7O2
Molecular Weight
588.08
Precautions
H302
References & Citations
[1]Aliagas-Martin I, Burdick D, Corson L, Dotson J, Drummond J, Fields C, Huang OW, Hunsaker T, Kleinheinz T, Krueger E, Liang J, Moffat J, Phillips G, Pulk R, Rawson TE, Ultsch M, Walker L, Wiesmann C, Zhang B, Zhu BY, Cochran AG.A class of 2,4-bisanilinopyrimidine Aurora A inhibitors with unusually high selectivity against Aurora B.J Med Chem. 2009 May 28;52 (10) :3300-7.
Shipping Conditions
Room Temperature
Storage Conditions
-20°C, 3 years; 4°C, 2 years (Powder)
Scientific Category
Reference compound1
Clinical Information
No Development Reported
Isoform
Aurora A; Aurora B
Available Sizes
Frequently Asked Questions
More Discoveries
Explore Other Products
Browse additional items from our catalog
PB9058-FITC 100 µg/Vial
Anti-CD10/MME Antibody Picoband®, FITC Conjugate
Sign In for Pricing
View Details 
K1371907 1.0 µg DNA
MYC sgRNA CRISPR/Cas9 All-in-One Lentivector (Human) (Target 2)
Sign In for Pricing
View Details MBS2802298-01 48 Tests
Human Anti-tissue transglutaminase IgG (tTG-IgG) ELISA Kit
Sign In for Pricing
View Details